• DelMar Pharmaceuticals Receives Nasdaq Bid Price Extension

    4 days ago - By San Diego Biotechnology

    SAN DIEGO, March 26, 2020 /PRNewswire/ - DelMar Pharmaceuticals, Inc. , a biopharmaceutical company focused on the development of new solid tumor cancer therapies, announced that it has received a listing e......
    Read more ...